Clinical investigation of human plasma-derived von Willebrand factor products

Current effective version

PDF iconAdopted guideline

Reference numberCPMP/BPWG/220/02
Effective from01/06/2006
KeywordsVon Willebrand factor, von Willebrand disease
DescriptionThis document summarises the clinical trials required for authorisation of new and modified human plasma derived von Willebrand factor products.

Related content

How useful was this page?

Add your rating